Key result
Losartan reduces LV mass index by ~20 g/m2 and improves diastolic filling over 12 weeks.
Why the study?
Short-term treatment with angiotensin converting enzyme inhibitors improves LV diastolic function, LV hypertrophy, and aortic stiffness in essential hypertension, but effects of angiotensin II receptor antagonists like Losartan are unclear.
Does losartan 50 mg daily improve left ventricular diastolic function, left ventricular mass, and aortic stiffness in previously untreated hypertensive patients over 50 years old?
Does losartan 50 mg daily improve left ventricular diastolic function, left ventricular mass, and aortic stiffness in previously untreated hypertensive patients over 50 years old?
Short-term treatment with losartan in essential hypertension effectively lowers blood pressure and improves left ventricular hypertrophy and diastolic function, but does not alter aortic stiffness.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for losartan effects on LV mass and diastolic function in hypertension; leaves open aortic stiffness changes pending randomized data.
Background and Objectives:Even short-term treatment with angiotensin converting enzyme inhibitor in essential hypertension has been known to improve left ventricular (LV) diastolic function, LV hypertrophy (LVH), and aortic stiffness.The purpose of this study was to examine the effects of angiotensin II receptor antagonist (Losartan) on LV diastolic function, LVH, and aortic stiffness in essential hypertension.Materials and Methods: Twenty-three hypertensive patients who were aged over 50 years, previously untreated, and without cardiac, renal, neurologic disease, or diabetes, were studied.Before and 12 weeks after monotherapy with Losartan 50 mg q.d., (1) supine arterial blood pressure by sphygmomanometry, (2) interventricular septum and LV posterior wall thickness, and LV end-diastolic dimension by M-mode echocardiography, (3) mitral peak E and A wave velocity by doppler echocardiography, (4) pulse wave velocity (PWV) in the descending aorta from aortic arch to the bifurcation by doppler echocardiography, were done.Results:Twelve weeks after treatment, systolic blood pressure was lowered from 168.2±3.5 mmHg to 142.9±2.9 mmHg (p<0.05),diastolic blood pressure from 98.5±2.4 mmHg to 87.5±1.3 mmHg (p<0.05).Peak E/A ratio was increased from 0.75±0.04 to 0.82±0.04(p< 0.05).LV mass was decreased from 267.5±15.8g to 235.6±12.6 g (p<0.05), and LV mass index from 166.8± 8.0 g/m 2 to 146.9±6.0 g/m 2 (p<0.05).However, there were no significant change in PWV (from 7.18±0.10m/sec to 7.23±0.30m/sec, p> 0.05), compliance (from 1.31±0.04 to 1.34±0.12,p> 0.05), and compliance index (from 0.16±0.01 to 0.15±0.01,p> 0.05).Conclusion:Short-term treatment with Losartan decreases blood pressure, improves LV diastolic function and LVH, but not aortic stiffness.( ( ( (Korean Circulation J 2000 ; 30( ( ( (11) ) ) ) : 1341-1349) ) ) ) KEY WORDS:Essential hypertension•Angiotensin II antagonist•Left ventricular diastolic function•Left ventricular mass•Aortic stiffness.논문접수일:2000년 10월 23일 심사완료일:2000년 12월 19일 교신저자:이무용, 330-714 충남 천안시 안서동 산 29 단국대학교 의과대학 내과학교실 전화:(041) 550-3920•전송:(041) 556-3256 E-mail:rheemy@anseo.dankook.ac.kr
No takes yet. Share an insight, caveat, or question.
Rhee et al. (2000) studied Essential hypertension (n=23). Losartan vs. Baseline (pre-treatment) was evaluated on Left ventricular mass index (g/m2) (MD -19.9 g/m2, p=<0.05). Losartan daily for 12 weeks reduced LV mass index from 166.8 to 146.9 g/m2 and increased peak E/A ratio from 0.75 to 0.82, without altering aortic PWV.
Synapse has enriched 10 related papers. Consider them for comparative context: